New frontiers in radioembolization

Arian Mansur, Peiman Habibollahi, Adam Fang, Armeen Mahvash, Vahid Etezadi, Robert P. Liddell, Juan C. Camacho, Emil I. Cohen, Nima Kokabi, Aravind Arepally, Christos Georgiades, Nariman Nezami

Research output: Contribution to journalReview articlepeer-review

Abstract

Radioembolization is a locoregional transarterial therapy that combines radionuclide and micron-sized beads to deliver radiation internally to the target tumors based on the arterial blood flow. While initially developed as a palliative treatment option, radioembolization is now used for curative intent treatment, neoadjuvant therapy, and method to downstage or bridge for liver transplant. Radioembolization has become increasingly utilized and is an important therapeutic option for the management of hepatocellular carcinoma and liver metastasis. This article provides an overview of the techniques, challenges, and novel developments in radioembolization, including new dosimetry techniques, radionuclides, and new target tumors.

Original languageEnglish (US)
JournalTherapeutic Advances in Medical Oncology
Volume16
DOIs
StatePublished - Jan 1 2024

Keywords

  • dosimetry
  • eye90
  • holmium
  • radioembolization
  • selective internal radiation therapy

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'New frontiers in radioembolization'. Together they form a unique fingerprint.

Cite this